期刊
TALANTA
卷 134, 期 -, 页码 165-172出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.talanta.2014.10.041
关键词
Therapeutic drug monitoring; dried blood spot; tricyclic antidepressants; LC-MS/MS
Therapeutic drug monitoring (TOM) of tricyclic antidepressants (TCAs) is considered useful in patients with major depressive disorder, since these drugs display large individual differences in clearance, and the therapeutic windows of these drugs are relatively small. We developed an assay for determination of amitriptyline (ATP), nortriptyline (NIP), imipramine (IMP), desipramine (DSP) clomipramine (CMP) and desmethyl-clomipramine (DCMP) in dried blood spots (DBS). A fast and robust LC-MS/MS method was developed and analytically validated for simultaneous determination of ATP, NTP, IMP, DSP, CMP, and DCMP in DBS. Six mm circles were punched out from DBS collected on Whatman DMPK-C paper and mixed with acetonitrile: methanol 1:3 containing the internal standard. The extract was analyzed by LC-MS/MS. Total LC-MS/MS runtime was 4.8 min. The assay was linear in the range 20-500 mu g/L, for all compounds. Overall-assay accuracy and precision were < 20% for the lower limit of quantification (LLOQ), except for CMP (CV=22.3%), and < 15% at other concentrations. The initial LLOQ was 20 mu g/L however for CMP and DMCP it was increased to 40 mu g/L. The blood volume per spot did not influence the results, but a low hematocrit ( <= 30%) was associated with a > 15% negative bias for all compounds. Punching at the perimeter of the blood spot instead of the center was associated with a positive bias. A good correlation was found between patients plasma and DBS samples of ATP, NTP and DMCP, but not for CMP. In addition, proportional differences were found. This LC-MS/MS method was analytically validated for determination of TCAs in DBS. Future validation will focus on the clinical application of the method. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据